Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buzyn

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Anticancer Research|August 5, 2010
Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical dataE Carreras, J Y Cahn, C Puozzo, et al.
Blood|November 11, 1999
Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patientsA Buzyn, F Petit, M Ostankovitch, et al.
Blood|June 25, 1998
Antileukemic HLA-restricted T-cell clones generated with naturally processed peptides eluted from acute myeloblastic leukemia blastsM Ostankovitch, A Buzyn, D Bonhomme, et al.
Transplantation|December 25, 2002
Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantationD McNeel, M T Rubio, G Damaj, et al.
Leukemia|June 24, 2005
DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratificationL Garçon, M Libura, E Delabesse, et al.
The New England Journal of Medicine|June 29, 1995
Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfaO Hermine, D Bouscary, A Gessain, et al.
Bone Marrow Transplantation|November 21, 2012
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie CellulaireS P Chantepie, M Mohty, R Tabrizi, et al.
Bone Marrow Transplantation|March 24, 2015
Changes in intensive care for allogeneic hematopoietic stem cell transplant recipientsE Lengliné, S Chevret, A-S Moreau, et al.
Bone Marrow Transplantation|January 11, 2005
Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosisO Thaunat, M A Alyanakian, S Varnous, et al.
Oncogene|February 19, 1999
Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patientM H Koken, M T Daniel, M Gianni, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Anticancer Research|August 5, 2010
Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical dataE Carreras, J Y Cahn, C Puozzo, et al.
Blood|November 11, 1999
Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patientsA Buzyn, F Petit, M Ostankovitch, et al.
Blood|June 25, 1998
Antileukemic HLA-restricted T-cell clones generated with naturally processed peptides eluted from acute myeloblastic leukemia blastsM Ostankovitch, A Buzyn, D Bonhomme, et al.
Transplantation|December 25, 2002
Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantationD McNeel, M T Rubio, G Damaj, et al.
Leukemia|June 24, 2005
DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratificationL Garçon, M Libura, E Delabesse, et al.
The New England Journal of Medicine|June 29, 1995
Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfaO Hermine, D Bouscary, A Gessain, et al.
Bone Marrow Transplantation|November 21, 2012
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie CellulaireS P Chantepie, M Mohty, R Tabrizi, et al.
Bone Marrow Transplantation|March 24, 2015
Changes in intensive care for allogeneic hematopoietic stem cell transplant recipientsE Lengliné, S Chevret, A-S Moreau, et al.
Bone Marrow Transplantation|January 11, 2005
Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosisO Thaunat, M A Alyanakian, S Varnous, et al.
Oncogene|February 19, 1999
Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patientM H Koken, M T Daniel, M Gianni, et al.
Pageof 6